西作为抗抑郁药治疗的治疗窗口很窄
Lenka Seillier1, Barbora Čechová1, Alexandre Seillier2
1Department of Physiology, Third Faculty of Medicine, Charles University, Ke Karlovu 4, 120 00 Prague 2, Czech Republic.
Progress in neuro-psychopharmacology & biological psychiatry
|April 17, 2025
概括
单剂量psilocybin显示了抗抑郁药的潜力,但最佳的治疗效果仅在老鼠中介剂量 (0.32 mg/kg) 观察到,避免了较高剂量出现的不良影响.
科学领域:
- 神经科学是一个神经科学.
- 心理药理学 心理药理学
- 行为科学 行为科学
背景情况:
- 幻觉化合物psilocybin在单次使用后表现出快速和持续的抗抑郁作用.
- 为了获得治疗效益与副作用的最佳西剂量,需要进一步研究.
研究的目的:
- 为了确定抗抑郁药类效应的最佳剂量,
- 为了评估psilocybin的亲社会和改变快乐的影响.
- 检查剂量-反应关系的不良影响和神经生物学标志物.
主要方法:
- 威斯塔尔大鼠接受了单剂量 псилоцибин (0.13.2毫克/公斤).
- 行为测试包括强迫游泳测试 (FST),社交互动测试 (SIT) 和糖糖偏好测试 (SPT).
- 评估的头反应 (HTR),运动运动,体温,体重增加,以及海马/前额皮层BDNF水平.
主要成果:
- 一个中间的 псилоцибин剂量 (0.32 mg/kg) 在 FST,SIT 和 SPT 中产生了剂量依赖的抗抑郁药类效应,具有类似的 HTR 模式.
- 较高的psilocybin剂量 (1.0和3.2毫克/公斤) 缺乏抗抑郁作用,并导致身体温度降低,活动和体重增加等不良影响.
- 大脑衍生神经营养因子 (BDNF) 水平增加了剂量依赖,但线性,表明与观察到的行为影响的分离.
结论:
- 对于psilocybin的抗抑郁药物潜力而言,有一个狭窄的治疗窗口.
- 0.32 mg/kg的剂量似乎是最佳的,产生抗抑郁药类效应,而在较高剂量时没有观察到的不良影响.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
160
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
160
Antidepressant Drugs: Overview
316
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
316
Drug Therapy
28
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
28
Psychosis: Goals of Pharmacotherapy
95
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
95
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
41
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
41
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
227
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
227


